Update on vedolizumab in IBD: What have we learned?

Earn CME for related activities: hmpeducation.com/
New findings, new techniques, and recent efforts in research and discovery have changed the way physicians treat their patients - taking a more individualized approach. Mastering Clinical Challenges and Emerging Therapies in IBD, held in Chicago, Illinois on July 23, 2016 provided important clinical updates in the management of patients with inflammatory bowel disease.
In this presentation, Dr. David T. Rubin presents an update on the use of vedolizumab for inflammatory bowel disease (IBD).

[@StevenMoyleReacts]

So the percentage of ppl who actually achieved remission is not that high? In regular education level ppl lol. Is entyvio combined with any other medications or no? Thank you for the video

[@citrus1229]

hes a drug pusher nothing more